Nogueira, L.; Alvim, R.; Baker, H.; Nagar, K.; Thomas, J.; Alvim, L.; Kim, K.; Heller, D.A.; Reis, A.; Scherz, A.;
et al. Synergistic Efficacy of WST11-VTP and P-Selectin-Targeted Nanotherapy in a Preclinical Prostate Cancer Model. Cancers 2025, 17, 2361.
https://doi.org/10.3390/cancers17142361
AMA Style
Nogueira L, Alvim R, Baker H, Nagar K, Thomas J, Alvim L, Kim K, Heller DA, Reis A, Scherz A,
et al. Synergistic Efficacy of WST11-VTP and P-Selectin-Targeted Nanotherapy in a Preclinical Prostate Cancer Model. Cancers. 2025; 17(14):2361.
https://doi.org/10.3390/cancers17142361
Chicago/Turabian Style
Nogueira, Lucas, Ricardo Alvim, Hanan Baker, Karan Nagar, Jasmine Thomas, Laura Alvim, Kwanghee Kim, Daniel A. Heller, Augusto Reis, Avigdor Scherz,
and et al. 2025. "Synergistic Efficacy of WST11-VTP and P-Selectin-Targeted Nanotherapy in a Preclinical Prostate Cancer Model" Cancers 17, no. 14: 2361.
https://doi.org/10.3390/cancers17142361
APA Style
Nogueira, L., Alvim, R., Baker, H., Nagar, K., Thomas, J., Alvim, L., Kim, K., Heller, D. A., Reis, A., Scherz, A., & Coleman, J.
(2025). Synergistic Efficacy of WST11-VTP and P-Selectin-Targeted Nanotherapy in a Preclinical Prostate Cancer Model. Cancers, 17(14), 2361.
https://doi.org/10.3390/cancers17142361